Dr. Bar is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
34 Shelburne Rd
Stamford, CT 06902Phone+1 203-325-2695Fax+1 203-975-7842
Education & Training
- University of California (San Francisco)Fellowship, Hematology and Medical Oncology, 1987 - 1990
- New York Presbyterian Hospital (Columbia Campus)Residency, Internal Medicine, 1983 - 1986
- Columbia University Vagelos College of Physicians and SurgeonsClass of 1983
Certifications & Licensure
- CA State Medical License 1986 - Present
- CT State Medical License 1990 - 2026
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Greenwich Magazine Castle Connolly, 2008-2014
- Top Doctors: New York Metro Area Castle Connolly, 2002-2014
- New York Magazine: Top Doctors Castle Connolly, 2005-2009, 2011-2014
- Join now to see all
Clinical Trials
- Relating Clinical Outcomes in Multiple Myeloma to Personal Assessment of Genetic Profile Start of enrollment: 2011 Jul 01
- Lenalidomide Intensification in Patients With Serologic/Asymptomatic Progression of Multiple Myeloma While on Lenalidomide Maintenance Start of enrollment: 2011 Oct 28
Publications & Presentations
PubMed
- Pomalidomide/Daratumumab/Dexamethasone in Relapsed or Refractory Multiple Myeloma: Final Overall Survival From MM-014.Nizar J Bahlis, Christy Samaras, Donna Reece, Michael Sebag, Jeffrey Matous
Clinical Lymphoma, Myeloma & Leukemia. 2024-12-01 - 11 citationsPomalidomide, dexamethasone, and daratumumab immediately after lenalidomide-based treatment in patients with multiple myeloma: updated efficacy, safety, and health-rel...Nizar J Bahlis, David S Siegel, Gary J Schiller, Christy Samaras, Michael Sebag
Leukemia & Lymphoma. 2022-06-01 - 57 citationsPomalidomide, dexamethasone, and daratumumab in relapsed refractory multiple myeloma after lenalidomide treatmentDavid S. Siegel, Gary J. Schiller, Christy J. Samaras, Michael Sebag, Jesus G. Berdeja
Leukemia. 2020-05-06
Professional Memberships
- Member
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: